
Oluwatosin A. Ogunbiyi
Examiner (ID: 2427, Phone: (571)272-9939 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1123 |
| Issued Applications | 597 |
| Pending Applications | 149 |
| Abandoned Applications | 402 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9397097
[patent_doc_number] => 20140094504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/842861
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 49416
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13842861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/842861 | Human toll-like receptor inhibitors and methods of use thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9068189
[patent_doc_number] => 20130259945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ANTI-MALARIA COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/827469
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16186
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827469
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/827469 | Anti-malaria compositions and methods | Mar 13, 2013 | Issued |
Array
(
[id] => 11463860
[patent_doc_number] => 09580478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Vaccines comprising heat-sensitive transgenes'
[patent_app_type] => utility
[patent_app_number] => 13/795445
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 20522
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/795445 | Vaccines comprising heat-sensitive transgenes | Mar 11, 2013 | Issued |
Array
(
[id] => 10247343
[patent_doc_number] => 20150132339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/381090
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 87454
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381090 | ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS | Mar 6, 2013 | Abandoned |
Array
(
[id] => 9843680
[patent_doc_number] => 08945591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Methods and compositions involving immunostimulatory oligodeoxynucleotides'
[patent_app_type] => utility
[patent_app_number] => 13/786815
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9600
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13786815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/786815 | Methods and compositions involving immunostimulatory oligodeoxynucleotides | Mar 5, 2013 | Issued |
Array
(
[id] => 9936904
[patent_doc_number] => 08986709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Vaccine for prophylaxis or treatment of an allergen-driven airway pathology'
[patent_app_type] => utility
[patent_app_number] => 13/782754
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4995
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782754
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782754 | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology | Feb 28, 2013 | Issued |
Array
(
[id] => 8891148
[patent_doc_number] => 20130164332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'LAWSONIA VACCINE AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/769582
[patent_app_country] => US
[patent_app_date] => 2013-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12529
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13769582
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/769582 | LAWSONIA VACCINE AND METHODS OF USE THEREOF | Feb 17, 2013 | Abandoned |
Array
(
[id] => 9427064
[patent_doc_number] => 08703134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Targeted cryptosporidium biocides'
[patent_app_type] => utility
[patent_app_number] => 13/760448
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 103
[patent_figures_cnt] => 21
[patent_no_of_words] => 34730
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13760448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/760448 | Targeted cryptosporidium biocides | Feb 5, 2013 | Issued |
Array
(
[id] => 8963014
[patent_doc_number] => 20130202616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST BACTERIA EXPRESSING A CARBAPENEMASE'
[patent_app_type] => utility
[patent_app_number] => 13/749499
[patent_app_country] => US
[patent_app_date] => 2013-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9622
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749499
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/749499 | Compositions and methods for immunization against bacteria expressing a carbapenemase | Jan 23, 2013 | Issued |
Array
(
[id] => 9082053
[patent_doc_number] => 20130267583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/731492
[patent_app_country] => US
[patent_app_date] => 2012-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13321
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13731492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/731492 | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response | Dec 30, 2012 | Issued |
Array
(
[id] => 8903701
[patent_doc_number] => 20130171204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'SOFT FOOD COMPOSITION WITH PROBIOTICS AND PREBIOTICS FOR MASKING MEDICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/729133
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/729133 | SOFT FOOD COMPOSITION WITH PROBIOTICS AND PREBIOTICS FOR MASKING MEDICATIONS | Dec 27, 2012 | Abandoned |
Array
(
[id] => 11535945
[patent_doc_number] => 09610337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-04
[patent_title] => 'Prevention and treatment of mycobacterium infection'
[patent_app_type] => utility
[patent_app_number] => 14/367854
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 20786
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367854
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367854 | Prevention and treatment of mycobacterium infection | Dec 19, 2012 | Issued |
Array
(
[id] => 9812053
[patent_doc_number] => 20150023999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Novel Targets of Acinetobacter Baumannii'
[patent_app_type] => utility
[patent_app_number] => 14/362058
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23425
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/362058 | Targets of Acinetobacter baumannii | Nov 28, 2012 | Issued |
Array
(
[id] => 9490626
[patent_doc_number] => 20140141032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'TEMPO-mediated glycoconjugation of immunogenic composition against Campylobacter jejuni with improved structural integrity and immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 13/681773
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3910
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681773 | TEMPO-mediated glycoconjugation of immunogenic composition against Campylobacter jejuni with improved structural integrity and immunogenicity | Nov 19, 2012 | Abandoned |
Array
(
[id] => 8814195
[patent_doc_number] => 20130115240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'RECOMBINANT BCG STRAINS WITH ENHANCED ABILITY TO INHIBIT INTRACELLULAR MYCOBACTERIAL GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/672013
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7074
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672013 | RECOMBINANT BCG STRAINS WITH ENHANCED ABILITY TO INHIBIT INTRACELLULAR MYCOBACTERIAL GROWTH | Nov 7, 2012 | Abandoned |
Array
(
[id] => 8939503
[patent_doc_number] => 20130189300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'CARRIER MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 13/670727
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25183
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/670727 | Conjugates comprising an antigen and a carrier molecule | Nov 6, 2012 | Issued |
Array
(
[id] => 8821061
[patent_doc_number] => 20130122106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS'
[patent_app_type] => utility
[patent_app_number] => 13/656175
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4358
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656175 | DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS | Oct 18, 2012 | Abandoned |
Array
(
[id] => 13661277
[patent_doc_number] => 10160790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => HYR1-derived compositions and methods of treatment using same
[patent_app_type] => utility
[patent_app_number] => 14/344838
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23852
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344838
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344838 | HYR1-derived compositions and methods of treatment using same | Sep 13, 2012 | Issued |
Array
(
[id] => 8780585
[patent_doc_number] => 20130102560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES'
[patent_app_type] => utility
[patent_app_number] => 13/620216
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6834
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620216
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620216 | NUTRITIONAL COMPOSITION COMPRISING IMMUNOGLOBULINS AND OLIGOSACCHARIDES | Sep 13, 2012 | Abandoned |
Array
(
[id] => 9657450
[patent_doc_number] => 20140228455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND POSSIBLY BORRELIA, IN PATIENTS EXHIBITING SYMPTOMS OF DISEASE AND BEING BLOOD DONORS'
[patent_app_type] => utility
[patent_app_number] => 14/343567
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7814
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343567 | DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND POSSIBLY BORRELIA, IN PATIENTS EXHIBITING SYMPTOMS OF DISEASE AND BEING BLOOD DONORS | Sep 5, 2012 | Abandoned |